Literature DB >> 10207772

Evolving resistance patterns of Streptococcus pneumoniae: a link with long-acting macrolide consumption?

F Baquero1.   

Abstract

The Alexander Project indicates an increase in the prevalence of S. pneumoniae resistance to macrolide antibiotics. In some centers, the prevalence of S. pneumoniae macrolide resistance exceeds that of penicillin resistance. Centers with a high level of macrolide resistance tend to also have high levels of penicillin resistance. Antimicrobial use may be an important driver of resistance. The application of pharmacodynamic concepts suggests that bacterial exposure to low and prolonged concentrations of macrolides may have a role in the selection of resistance. Analysis of macrolide prescribing and resistance patterns indicates a correlation between increasing macrolide resistance and the increased use of newer, long-acting macrolides, although further study is required to investigate the causality of this correlation. In order to attempt to prevent the further spread of resistance, antibiotic choice should maximize the opportunity for bacterial eradication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207772     DOI: 10.1179/joc.1999.11.Supplement-2.35

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  29 in total

1.  Mechanisms of macrolide resistance in clinical pneumococcal isolates in France.

Authors:  F Fitoussi; C Doit; P Geslin; N Brahimi; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Role of global surveillance in combating bacterial resistance.

Authors:  A Marchese; G C Schito
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: results of a national surveillance study.

Authors:  R R Reinert; S Simic; A Al-Lahham; S Reinert; M Lemperle; R Lütticken
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

4.  Blood, tissue, and intracellular concentrations of erythromycin and its metabolite anhydroerythromycin during and after therapy.

Authors:  S Krasniqi; P Matzneller; M Kinzig; F Sörgel; S Hüttner; E Lackner; M Müller; M Zeitlinger
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

5.  Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.

Authors:  Miika Bergman; Solja Huikko; Pentti Huovinen; Pirkko Paakkari; Helena Seppälä
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

Review 6.  Role of beta-lactam agents in the treatment of community-acquired pneumonia.

Authors:  J Garau
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

7.  Macrolide resistance in Streptococcus pneumoniae: Fallacy or fact?

Authors:  Jm Conly; Bl Johnston
Journal:  Can J Infect Dis       Date:  2002-01

8.  Effects of antiviral usage on transmission dynamics of herpes simplex virus type 1 and on antiviral resistance: predictions of mathematical models.

Authors:  M Lipsitch; T H Bacon; J J Leary; R Antia; B R Levin
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

9.  Tensions in antibiotic prescribing: pitting social concerns against the interests of individual patients.

Authors:  Joshua P Metlay; Judy A Shea; Linda B Crossette; David A Asch
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

Review 10.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.